UCB SA (EBR: UCB) bets $1.15 bn on Neurona Therapeutics to push epilepsy treatment beyond symptom control
Tesco is the UK’s biggest grocer again — and its FY26 results explain exactly why Aldi and Lidl should be paying attention
Read More Pharma Industry News Pfizer’s inotuzumab ozogamicin gains FDA priority review in acute lymphoblastic leukemia Pfizer Inc. has received a priority review designation from the U.S. Food and Drug Administration (FDA) for its… bypharmanewsdailyFebruary 23, 2017
